Krystal Biotech Inc
KRYS
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.62B
Close$
$348.60
6.2% upside
Current Fair Value
6.2% upsideUndervalued by 6.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.62 Billion |
|---|---|
| Enterprise Value | $9.29 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $7.08 |
| Beta | 0.5 |
| Outstanding Shares | 29,529,000 |
Return
| Return on Equity | 17.77% |
|---|---|
| Return on Assets | 16.09% |
| Return on Invested Capital | 14.97% |
Valuation & Multiples
| P/E Ratio | 39.47 |
|---|---|
| PEG | 92.07 |
| Price to Sales | 23.45 |
| Price to Book Ratio | 7.14 |
| Enterprise Value to Revenue | 21.09 |
| Enterprise Value to EBIT | 45.18 |
| Enterprise Value to Net Income | 38 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$1.70
Average shareholder expectationRevenue Estimate
$120.93 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$1.86
Average shareholder expectationRevenue Estimate
$128.61 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2381▼ 14.21% |
|---|---|
| Total Calls | 4,200▼ 98.65% |
| Total Puts | 1,000▼ 99.15% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 26.81%▼ 71.19% |
|---|---|
| Total Invested | $2.74B▼ 62.63% |
| Investors Holding | 192▼ 188.00% |
ESG Score
No data